Withdrawal of LDT Rule Provides Regulatory Clarity and Reimbursement Guidance for Laboratories
The End of an Era: FDA is Rescinding Long-Contested LDT Rule for Labs
Category: Quadax Blog
Withdrawal of LDT Rule Provides Regulatory Clarity and Reimbursement Guidance for Laboratories
In our Back to School Era: Grading Revenue Cycle Vendors Like a Pro
Score Your EDI Clearinghouse Partners: Boost Efficiency and Say Goodbye to Low Marks.
UnitedHealth Group’s Turmoil: The Impact on Labs and Pathology Groups
Rising costs, regulatory scrutiny, and shifting payer dynamics could reshape lab and pathology practice operations and reimbursements.
From Red Flags to Readiness: How Labs Can Stay Ahead of Audit Risks
With $1.2B in improper lab payments projected, payers are ramping up audits—putting clinical labs under intense scrutiny.
Healthcare’s New Law: Preparing for the “One Big Beautiful Bill” Act
The new law brings transformative changes to Medicare, Medicaid, and patient cost-sharing, requiring providers to strategically adapt revenue cycle operations.
Front-End RCM: How Patient Access & Engagement Tools Yield Big Returns
Optimize revenue performance, ease administrative burdens, and deliver a seamless, patient-centered experience from the very first interaction.
Is Your Healthcare Billing Partner Still Delivering?
As office demands grow, healthcare providers are seeking advanced tech, responsive support, and proven results.
The Hidden Risk of a Rapid RCM Vendor Implementation
For laboratories and pathologists, a strong revenue cycle management (RCM) implementation isn’t about speed—it’s about setting up for long-term success.
Digitizing Remittance Management: The Key to Faster Payment Posting
A modern approach to remittance management empowers your staff to work smarter, not harder.
Turn the Summer Slowdown into Reclaimed Revenue Potential
Why Now Is the Right Time for Labs to Reevaluate Their RCM Partner
